Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70

NCT00864721 is registered in ClinicalTrials.gov with US Oncology Research as lead sponsor.

NCT NCT00864721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00864721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Sunitinib Malate in Previously Untreated NSCLC Patients Over the Age of 70
Lead sponsor
US Oncology Research
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2009
Completion date
July 31, 2012
Enrollment
63 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer